Short and unexpectedly potent 3-pyrrolidinone type inhibitors of HIV-1 replication

Author： Bouygues M.   Medou M.   Chermann J.-C.   Camplo M.   Kraus J.-L.  

Publisher： Elsevier

ISSN： 0223-5234

Source： European Journal of Medicinal Chemistry, Vol.33, Iss.6, 1998-06, pp. : 445-450

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Computer-Aided Design, Synthesis, and Biological Activity Evaluation of Potent Fusion Inhibitors Targeting HIV-1 gp41

By  

Medicinal Chemistry, Vol. 7, Iss. 4, 2011-07 ,pp. : 309-316

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the DABOs Family as Potent HIV-1 non-Nucleoside Reverse Transcriptase Inhibitors

By  

Current Medicinal Chemistry, Vol. 18, Iss. 16, 2011-06 ,pp. : 2376-2385

Bentham Science Publishers

Access to resources Recommend Favorite

3D-QSAR Selectivity Analysis of 1-Adamantyl-3-Heteroaryl Urea Analogs as Potent Inhibitors of Mycobacterium tuberculosis

By  

Current Computer - Aided Drug Design, Vol. 11, Iss. 2, 2015-09 ,pp. : 164-183

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of HIV-1 Entry

By  

Current Pharmaceutical Design, Vol. 19, Iss. 10, 2013-03 ,pp. : 1784-1799

Bentham Science Publishers

Access to resources Recommend Favorite

VPAC1 potent facilitator of HIV-1 infection

By  

Inpharma, Vol. 1, Iss. 1330, 2002-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite